COVID-19 vaccine, FDA
Digest more
The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most at-risk Americans this fall.
Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults.
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy
Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who have at least one underlying condition that puts them at higher risk of severe illness.
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter